Endovascular Thrombectomy Versus Medical Management in Isolated M2 Occlusions: Pooled Patient-Level Analysis from the

Amrou Sarraj1,2, Mark Parsons3, Andrew Bivard4,5

  • 1Case Western Reserve University, Neurology, Cleveland, OH, USA.

Annals of Neurology
|February 20, 2022
PubMed
Abstract

Insights

Endovascular thrombectomy (EVT) improved functional outcomes for M2 occlusion stroke patients compared to medical management (MM). EVT benefits were most significant in patients with perfusion mismatch and higher stroke severity.

Area of Science:

  • Neurology
  • Interventional Cardiology
  • Stroke Medicine

Background:

  • M2 segment occlusions represent a significant cause of ischemic stroke.
  • Optimal treatment strategies for M2 occlusions remain under investigation, balancing reperfusion efficacy with procedural risks.

Purpose of the Study:

  • To compare functional and safety outcomes of endovascular thrombectomy (EVT) versus medical management (MM) in patients with M2 occlusions.
  • To analyze the association of EVT with perfusion imaging mismatch and stroke severity.

Main Methods:

  • A pooled analysis of 3 randomized controlled trials and 2 nonrandomized studies.
  • Evaluated 90-day functional independence (modified Rankin Scale 0-2) in 517 patients with M2 occlusions.
  • Subgroup analyses were performed based on mismatch profile and stroke severity (NIHSS).

Main Results:

  • EVT was associated with higher rates of functional independence (68.3% vs. 61.6%) and improved modified Rankin Scale outcomes compared to MM.
  • EVT demonstrated reduced mortality (5% vs. 10%).
  • Benefits of EVT were more pronounced in patients with a perfusion mismatch profile and moderate to severe strokes (NIHSS > 6-10).

Conclusions:

  • Endovascular thrombectomy is associated with improved clinical outcomes in patients with M2 occlusion stroke.
  • Perfusion imaging mismatch and higher stroke severity identify patient subgroups who benefit most from EVT.